Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma
- 4 January 2021
- journal article
- research article
- Published by Springer Nature in Updates in Surgery
- Vol. 73 (3) , 947-953
Abstract
The utilization of minimally invasive distal pancreatectomy (MIDP) is increasing, yet debate remains regarding its oncologic safety in the setting of pancreatic adenocarcinoma (PDAC). Herein we present our institutional experience with robotic (RDP), laparoscopic (LDP), and open distal pancreatectomy (ODP) in the setting of PDAC. Retrospective review of a prospectively collected single institutional database of patients undergoing consecutive ODP, LDP, and RDP for left-sided PDAC between January 2008 and December 2019 at the University of Pittsburgh Medical Center (UPMC) was done. Perioperative and postoperative outcomes were compared using non-parametric testing and Fischer exact or chi-squared testing. Kaplan–Meier survival curves for disease-free survival and overall survival were compared by Log-Rank sum test. Backward Cox-proportional hazard regression analysis was used to determine if the operative approach was an independent predictor of recurrence and overall survival. Over 12 years, 146 consecutive distal pancreatectomies for PDAC were performed, of which 28.1% ODP, 60.3% RDP, and 11.6% LDP. There were no statistical differences in patients’ baseline characteristics, including gender, comorbidities, prior abdominal surgeries, and AJCC8th stage (p > 0.05). Postoperatively, there was no difference in the frequency of major complications (p = 0.414), CR-POPF (p = 0.563), or DGE (p = 0.179). The median overall survival was 28.4 months for ODP, 34.6 months for RDP, and 32.5 months for LDP (Log Rank p = 0.914). On multivariate Cox proportional hazard analysis, the surgical approach was not associated with overall survival. This comparative analysis suggests a non-inferiority of RDP platforms, compared to LDP and classic ODP. The merits of MIS pancreatic surgery in the setting of PDAC should be evaluated in future prospective studies with care to analyze RDP outcomes separately from LDP.Keywords
This publication has 23 references indexed in Scilit:
- Long‐term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinomaJournal of Surgical Oncology, 2020
- Comparison of robotic vs laparoscopic vs open distal pancreatectomy. A systematic review and network meta-analysisHPB, 2019
- Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 PatientsSurgical Innovation, 2019
- Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2019
- Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA)Annals of Surgery, 2019
- Robotic versus laparoscopic distal pancreatectomy: an up-to-date meta-analysisBMC Surgery, 2017
- The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high‐volume pancreatic centreHPB, 2015
- Systematic Review and Meta-Analysis of Case-Matched Studies Comparing Open and Laparoscopic Distal PancreatectomyPancreas, 2012
- Robotics in General SurgeryArchives of Surgery, 2003
- Robotic Resection of Pancreatic Neuroendocrine TumorJournal of Laparoendoscopic & Advanced Surgical Techniques, 2003